Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PolyNeuroS is a private French biotech and diagnostics company focused on immunochemistry and immunopathology applications in neurodegenerative disease. The company has been described as developing small-molecule antibodies, antibody-related research products, and diagnostic kits for disease detection and patient monitoring. Publicly available descriptions indicate a focus on Parkinson's disease and amyotrophic lateral sclerosis, with broader references to autoimmune, inflammatory, infectious, and chronic diseases through its patent and trademark footprint. PolyNeuroS appears to combine a diagnostic platform with early therapeutic research rather than operating a disclosed late-stage clinical pipeline. The company is small, private, and based in the Bordeaux area of France.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PolyNeuroS.